With over 50 years of innovation in the U.S., Boehringer Ingelheim maintains numerous sites across the country, including research & development (R&D) and manufacturing facilities for our medicines. There are over 9,000 employees representing all 50 states. As a top global pharmaceutical company that develops innovative therapies in areas of high unmet medical need for the patients and animals we serve, Boehringer consistently ranks among the top of its peers for investments in R&D. Boehringer has remained independent since the company’s founding in 1885, which provides the freedom to take a long-term approach in achieving breakthroughs that transform patients’ lives.